Atossa Therapeutics (ATOS) Earnings Date & Reports
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology... Show more
ATOS is expected to report earnings to fall 3.57% to -6 cents per share on April 01
Q4'25
Est.
$-0.07
Q3'25
Missed
by $0.01
Q2'25
Missed
by $0.01
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.02
The last earnings report on November 12 showed earnings per share of -7 cents, missing the estimate of -5 cents. With 781.88K shares outstanding, the current market capitalization sits at 103.03M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ATOS showed earnings on November 12, 2025. You can read more about the earnings report here.